Basic and Clinical Approaches to Lyme Disease: A Lyme Disease Foundation SymposiumBOSLER, Edward.Clinical infectious diseases. 1997, Vol 25, issn 1058-4838, 78 p., SUP1Conference Proceedings

Tetracycline therapy for chronic Lyme diseaseDONTA, S. T.Clinical infectious diseases. 1997, Vol 25, pp S52-S56, issn 1058-4838, SUP1Conference Paper

Why is chronic Lyme borreliosis chronic?ABERER, E; KOSZIK, F; SILBERER, M et al.Clinical infectious diseases. 1997, Vol 25, pp S64-S70, issn 1058-4838, SUP1Conference Paper

Functional brain imaging and neuropsychological testing in Lyme diseaseFALLON, B. A; DAS, S; PLUTCHOK, J. J et al.Clinical infectious diseases. 1997, Vol 25, pp S57-S63, issn 1058-4838, SUP1Conference Paper

Activity of sera from patients with Lyme disease against Borrelia burgdorferiPAVIA, C. S; WORMSER, G. P; NORMAN, G. L et al.Clinical infectious diseases. 1997, Vol 25, pp S25-S30, issn 1058-4838, SUP1Conference Paper

Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferiBARTHOLD, S. W; FENG, S; BOCKENSTEDT, L. K et al.Clinical infectious diseases. 1997, Vol 25, pp S9-S17, issn 1058-4838, SUP1Conference Paper

Pathological manifestations in murine Lyme disease : Association with tissue invasion and spirochete persistenceWEIS, J. J; YANG, L; SEILER, K. P et al.Clinical infectious diseases. 1997, Vol 25, pp S18-S24, issn 1058-4838, SUP1Conference Paper

The cold zone : A curious convergence of tick-transmitted diseasesPERSING, D. H.Clinical infectious diseases. 1997, Vol 25, pp S35-S42, issn 1058-4838, SUP1Conference Paper

Specific issues in the design and implementation of an efficacy trial for a Lyme disease vaccineMEURICE, F; PARENTI, D; FU, D et al.Clinical infectious diseases. 1997, Vol 25, pp S71-S75, issn 1058-4838, SUP1Conference Paper

Invasion and cytopathic killing of human lymphocytes by spirochetes causing lyme diseaseDORWARD, D. W; FISCHER, E. R; BROOKS, D. M et al.Clinical infectious diseases. 1997, Vol 25, pp S2-S8, issn 1058-4838, SUP1Conference Paper

Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological featuresDUMLER, J. S.Clinical infectious diseases. 1997, Vol 25, pp S43-S47, issn 1058-4838, SUP1Conference Paper

The antimicrobial agent melittin exhibits powerful in vitro inhibitory effects on the Lyme disease spirocheteLUBKE, L. L; GARON, C. F.Clinical infectious diseases. 1997, Vol 25, pp S48-S51, issn 1058-4838, SUP1Conference Paper

The Western immunoblot for Lyme disease : Determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panelsTILTON, R. C; SAND, M. N; MANAK, M et al.Clinical infectious diseases. 1997, Vol 25, pp S31-S34, issn 1058-4838, SUP1Conference Paper